TMEM97-BLMH Fusion FISH Probe
The TMEM97-BLMH Fusion FISH Probe is used to confirm a fusion of the TMEM97 and BLMH genes. The fusion of the TMEM97 and BLMH genes has been associated with Prostate Adenocarcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| TMEM97-BLMH-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| TMEM97-BLMH-20-RERE | 20 (40 μL) | 200 μL |
|
|
| TMEM97-BLMH-20-REOR | 20 (40 μL) | 200 μL |
|
|
| TMEM97-BLMH-20-REGO | 20 (40 μL) | 200 μL |
|
|
| TMEM97-BLMH-20-REGR | 20 (40 μL) | 200 μL |
|
|
| TMEM97-BLMH-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| TMEM97-BLMH-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| TMEM97-BLMH-20-OROR | 20 (40 μL) | 200 μL |
|
|
| TMEM97-BLMH-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| TMEM97-BLMH-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| TMEM97-BLMH-20-GORE | 20 (40 μL) | 200 μL |
|
|
| TMEM97-BLMH-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| TMEM97-BLMH-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| TMEM97-BLMH-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| TMEM97-BLMH-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| TMEM97-BLMH-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| TMEM97-BLMH-20-GROR | 20 (40 μL) | 200 μL |
|
|
| TMEM97-BLMH-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| TMEM97-BLMH-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| TMEM97-BLMH-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| TMEM97-BLMH-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| TMEM97-BLMH-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| TMEM97-BLMH-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| TMEM97-BLMH-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| TMEM97-BLMH-20-AQAQ | 20 (40 μL) | 200 μL |
|
BLMH Gene Summary
Bleomycin hydrolase (BMH) is a cytoplasmic cysteine peptidase that is highly conserved through evolution; however, the only known activity of the enzyme is metabolic inactivation of the glycopeptide bleomycin (BLM), an essential component of combination chemotherapy regimens for cancer. The protein contains the signature active site residues of the cysteine protease papain superfamily. [provided by RefSeq, Jul 2008]
Gene Name: Bleomycin Hydrolase
Chromosome: CHR17: 28575212 -28619184
Locus: 17q11.2
TMEM97 Gene Summary
TMEM97 is a conserved integral membrane protein that plays a role in controlling cellular cholesterol levels (Bartz et al., 2009 [PubMed 19583955]).[supplied by OMIM, Aug 2009]
Gene Name: Transmembrane Protein 97
Chromosome: CHR17: 26646120 -26655711
Locus: 17q11.2
Gene Diseases
The TMEM97 BLMH Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Prostate Adenocarcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|